Literature DB >> 12693037

Allosteric binding of an Ag+ ion to cerium(IV) bis-porphyrinates enhances the rotational activity of porphyrin ligands.

Masato Ikeda1, Masayuki Takeuchi, Seiji Shinkai, Fumito Tani, Yoshinori Naruta, Shigeru Sakamoto, Kentaro Yamaguchi.   

Abstract

A series of cerium(IV) bisporphyrinate double-deckers [Ce(bbpp)2] (BBPP = 5,15-bis(4-butoxyphenyl) porphyrin dianion), [Ce(tmpp)2] (TMPP = 5,10,15,20-tetrakis(4-methoxyphenyl)-porphyrin dianion), [Ce(tfpp)2] (TFPP = 5,10,15,20-tetrakis(4-fluorophenyl)porphyrin dianion), [Ce(tmcpp)2] (TMCPP = 5,10,15,20-tetrakis(4-methoxycarbonylphenyl)porphyrin dianion), and [Ce(tmpp)(tmcpp)] was prepared. They bind three Ag+ ions to their concave porphyrin pi subunits (pi-clefts) according to a positive homotropic allosteric mechanism with Hill coefficients (nH) of 1.7-2.7. The rotation rates of the porphyrin ligands in [Ce(bbpp)2] were evaluated to be 200 s-1 at 20 degrees C (delta G++293 = 14.1 kcal mol-1) and 220 s-1 at -40 degrees C (delta G++233 = 11.0 kcal mol-1) without and with Ag+ ions, respectively. These results consistently support our unexpected finding that Ag+ binding can accelerate rotation of the porphyrin ligand. On the basis of UV-visible, 1H NMR, and resonance Raman spectral measurements, the rate enhancement of the rotational speed of the porphyrin ligands is attributed to conformational changes of the porphyrin in cerium(IV) bis-porphyrinate induced by binding of Ag+ guest ions in the clefts. This novel concept of positive homotropic allosterism is applicable to the molecular design of various supramolecular and switch-functionalized systems.

Entities:  

Year:  2002        PMID: 12693037

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Synthesis of Bis{meso-Tetrakis(4-N-alkylpyridiniumyl)porphyrinato}cerium and Its Redox Switching Behavior.

Authors:  Toshio Nishino; Yasuyuki Yamada; Ayumi Yamamoto; Kentaro Tanaka
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.